Medinet (2370) · InitiativeRestated
mRNA CAR-T Joint Research
First written in FY2017. 1 of 2 entries say "Restated". Latest entry: FY2019.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
mRNA CAR-T collaborative research with Osaka UniversityA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2019RestatedAnnual report
「The Company is conducting joint research on mRNA CAR-T with the Graduate School of Pharmaceutical Sciences at Osaka University and is currently considering nonclinical pharmacology and efficacy studies to select the target tumor.」
The Company is continuing its joint research on mRNA CAR-T and considering nonclinical pharmacology and efficacy studies to select the target tumor. - FY2017First statedAnnual report
「We are conducting joint research on mRNA CAR-T with the Graduate School of Pharmaceutical Sciences at Osaka University. After confirming tumor-suppressive effects in a mouse model, we published the results in an international academic journal in November 2016.」
The joint research with Osaka University confirmed tumor-suppressive effects in a mouse model, and the results were published in an international academic journal.